0GA Stock Overview

Develops and sells medical techniques and mathematical models. More details

0GA fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	2/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Rewards

Revenue is forecast to grow 53.83% per year

Risk Analysis

Negative shareholders equity

Earnings have declined by 15.5% per year over past 5 years

Makes less than USD$1m in revenue (€301K)

Shares are highly illiquid

+ 1 more risk

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

My Notes

Capture your thoughts, links and company narrative

Predilife S.A. Competitors

co.don

XTRA:CNW

€6.5m

Medigene

XTRA:MDG1

€27.5m

2invest

XTRA:2INV

€68.4m

Heidelberg Pharma

XTRA:HPHA

€110.5m

Price History & Performance

Summary of share price highs, lows and changes for Predilife
Historical stock prices
Current Share Price	€3.88
52 Week High	€3.96
52 Week Low	€3.68
Beta	0.39
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	5.43%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	0GA	DE Biotechs	DE Market
7D	n/a	-11.3%	3.0%
1Y	n/a	-15.0%	19.3%

Return vs Industry: Insufficient data to determine how 0GA performed against the German Biotechs industry.

Return vs Market: Insufficient data to determine how 0GA performed against the German Market.

Price Volatility

Is 0GA's price volatile compared to industry and market?
0GA volatility
0GA Average Weekly Movement	n/a
Biotechs Industry Average Movement	8.4%
Market Average Movement	4.8%
10% most volatile stocks in DE Market	11.4%
10% least volatile stocks in DE Market	2.5%

Stable Share Price: 0GA's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine 0GA's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2004	19	Stephane Ragusa	www.predilife.com

Predilife S.A. develops and sells medical techniques and mathematical models. The company provides prevention and breast check-up tests. Its products include MammoRisk, a test for predicting the development of breast cancer based on the patient’s individual risk; and DenSeeMammo, a breast density measurement software, as well as a medical device for the prediction of prostate cancer risk.

Predilife S.A. Fundamentals Summary

How do Predilife's earnings and revenue compare to its market cap?
0GA fundamental statistics
Market cap	€14.97m
Earnings (TTM)	-€4.66m
Revenue (TTM)	€300.87k

49.7x

P/S Ratio

-3.2x

P/E Ratio

Is 0GA overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0GA income statement (TTM)
Revenue	€300.87k
Cost of Revenue	-€920.84k
Gross Profit	€1.22m
Other Expenses	€5.88m
Earnings	-€4.66m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-1.25
Gross Margin	406.06%
Net Profit Margin	-1,548.80%
Debt/Equity Ratio	-128.1%

How did 0GA perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/19 20:43
End of Day Share Price	2025/02/18 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Predilife S.A. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Jean-Pierre Loza	In Extenso Financement & Marché